AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Health Check: When Record Results Fall Short of Investor Expectations
February 06, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,PolyNovo Reports Market Fluctuations:,Despite strong financial results, PolyNovo (ASX:PNV) experienced stock price movements due to revenue and profit figures falling slightly below market expectations.,Cyclopharm Expands in the US:,Cyclo...
Can This New Patent Propel NUZ-001 Forward?
February 05, 2025 06:11 PM AEDT| By Team Kalkine MediaHighlights,Neurizon secures a U.S. patent for NUZ-001’s novel method of use.,The intellectual property framework receives a robust enhancement.,Licensing and commercialization frameworks gain strategic reinforcement.,Neurizon (ASX:NUZ) recently achie...
Can ASX:CYP Reshape Stem Cell Manufacturing?
February 05, 2025 06:10 PM AEDT| By Team Kalkine MediaHighlights,Cynata herapeutics (ASX:CYP) develops iPSC-derived MSCs comparable to traditional bone marrow sources in regenerative function.,A peer-reviewed study conducted with a renowned research center examines the attributes and consistency of vari...
Little Green Pharma Acquires Health House in Strategic Expansion, Shares Rise 4%
February 05, 2025 03:22 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition:,Little Green Pharma acquires Health House to enhance vertical integration.,Low-Cost Deal:,The acquisition cost is,$375,000,, a fraction of the,$10.9 million,price tag listed in 2024.,Market Reaction:,LGP shares rose,...
Has Neurizon Therapeutics Secured a Pivotal US Patent for NUZ-001?
February 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,US patent secures protection for NUZ-001 in neurodegenerative conditions and cancer.,Patent follows FDA Orphan Drug Designation, reinforcing US market strategy.,Protection for NUZ-001 extends in the United States until the late 2030s,Neuri...
Why Has MedAdvisor (ASX:MDR) Seen a Significant Decline in Share Price?
February 04, 2025 01:30 PM AEDT| By Team Kalkine MediaHighlights:,MedAdvisor's share price has experienced a noticeable decline recently.,The company's price-to-sales ratio is significantly lower than the healthcare industry average.,Revenue growth projections for MedAdvisor fall behind the industry’s e...
Wellnex Life (ASX:WNX) Secures TGA Approval for Liquid Paracetamol & Caffeine Soft Gel
February 04, 2025 01:14 PM AEDT| By Team Kalkine MediaHighlights:,TGA grants Market Authorisation (MA) for the innovative liquid paracetamol and caffeine combination.,Wellnex,Life (,ASX:WNX,) experiences a 6% share price increase amid low trading volume.,Expansion of the product portfolio strengthens th...
Breakthrough Preclinical Study: ARG-007 Demonstrates Neuroprotective Action in Traumatic Brain Injury Models (ASX:AGN)
February 04, 2025 01:12 PM AEDT| By Team Kalkine MediaHighlights,Neuroinflammation Reduction:,Early-stage evidence,indicates,that ARG-007 significantly reduces neuroinflammation in a rat model of traumatic brain injury (TBI).,Biomarker Normalization:,Biomarker levels associated with TBI in treated rats...
Nufarm Shares Surge on Strong Growth Outlook for Omega-3 Products
February 04, 2025 11:27 AM AEDT| By Team Kalkine MediaHighlights,Nufarm shares rise 4.8% to AU$3.73, their highest level since December 13.,FY25 revenue forecast for plant-based omega-3 products doubles to AU$100 million, up from AU$50 million in FY24.,Shares spiked as much as 7.1% intraday, marking the...
Noxopharm's Flagship Lupus Therapy Clears Early Safety Hurdles in Lab Tests
February 04, 2025 11:16 AM AEDT| By Team Kalkine MediaHighlights,SOF-SKN Advances:,The experimental topical drug, SOF-SKN, has successfully passed its first round of in vitro safety tests.,Robust Safety Profile:,Early studies,indicate,minimal risk for genetic mutations and cardiac toxicity, and the form...
Pro Medicus Surges to Record High on $53 Million U.S. Contract Win
February 04, 2025 11:08 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus shares hit a record high of $281.25, gaining 4% in morning trade.,The company secured a seven-year, $53 million contract with U.S.-based healthcare system BayCare.,Shares have soared nearly 160% over the past year.,Shares of Pr...
Noxopharm Shares Surge as Lupus Drug Clears Key Safety Tests
February 04, 2025 11:03 AM AEDT| By Team Kalkine MediaHighlights,Noxopharm shares jumped 11% to 10cps following positive test results.,SOF-SKN, a topical lupus treatment, passed first-stage in vitro safety tests.,Final preclinical study to be completed before human trials begin in 2025.,Biotech firm Nox...
EZZ Life Science Experiences Significant Growth with Record-Breaking Revenue and US Expansion Advancements
February 04, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,EZZ Life Science recorded substantial revenue growth in the first half of the fiscal year, demonstrating strong financial performance.,Expansion into Chinese markets saw impressive sales increases during major global shopping events.,Strat...
Biotech Ventures Eye Expansive Growth Amid Approvals and Strategic Shifts
February 04, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) anticipates significant revenue growth following upcoming FDA approvals for innovative imaging products in 2024.,Patrys (ASX:PAB) pivots to new therapeutic opportunities with its deoxymab platform, broadenin...
Resmed's Evolving Journey in Sleep Health and Digital Care
February 04, 2025 11:00 AM AEDT| By Team Kalkine MediaResmed's Evolving Journey in Sleep Health and Digital Care
Will Wellnex Life's TGA Achievement Expand Its Global Health Reach?
February 04, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,•,Wellnex Life (ASX:WNX) secures TGA market authorisation for its liquid paracetamol plus caffeine soft gel.,• The approval strengthens a diverse portfolio of liquid soft gel formulations.,• Collaboration with major retail and global heal...
Is Paragon Care Limited (ASX:PGC) Accurately Priced in the Market?
February 03, 2025 03:27 PM AEDT| By Team Kalkine MediaHighlights:,Paragon Care (ASX:PGC) appears to be overvalued by approximately 23%.,Industry peers of PGC are currently trading at a significant discount compared to their intrinsic value.,A Discounted Cash Flow (DCF) model highlights discrepancies bet...
Is Argenica Therapeutics Managing Cash Burn Effectively?
February 03, 2025 03:26 PM AEDT| By Team Kalkine MediaHighlights:,Argenica Therapeutics (ASX:AGN) has a solid cash runway of over three years.,Cash burn increased significantly last year, rising by more than half.,Company is well-positioned to raise additional funds with minimal shareholder dilution.,In...
Has Bioxyne's Impressive Growth Signal a New Era for the Company?
February 03, 2025 03:24 PM AEDT| By Team Kalkine MediaHighlights:,Bioxyne's stock has surged significantly over the past year.,Revenue growth has been a key factor behind the strong share performance.,Despite challenges, market sentiment remains high.,Bioxyne Limited (ASX:BXN), a prominent player in the...
Tariff Pressures Forecast to Increase Costs for Fisher & Paykel (ASX:FPH) in FY26
February 03, 2025 11:15 AM AEDT| By Team Kalkine MediaHighlights,Tariffs imposed on Mexico are,anticipated,to elevate manufacturing costs in FY26.,Approximately 50% of manufacturing occurs in Mexico and 50% in New Zealand, with 43% of first-half FY25 revenues generated from the U.S.,While FY25 net profi...
Advertise your brand on Kalkine Media